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Abstract
Background and Aim: Hyperlipidemia is an important risk factor for cardiovascular disease. The use of statins has adverse 
side effects that result in oxidative stress disorders. The objective of this study was to investigate the antihyperlipidemic 
effect of a combination of Cinnamomum burmannii and Eleutherine palmifolia extract in high-fat diet (HFD)-induced 
hyperlipidemia mice.
Materials and Methods: Mice were divided into eight groups (n=4): Control group or healthy mice (normal), HFD-
induced hyperlipidemic mice without any treatment (CE0), HFD-induced hyperlipidemic mice treated with 3.6 mg/kg body 
weight (BW) atorvastatin (atorvastatin), and HFD-induced hyperlipidemic mice treated with a combination of C. burmannii 
and E. palmifolia in the following ratios: 300:0 (C300), 225:75 (C225), 150:150 (CE150), 75:225 (E225), and 0:300 
(E300). Mice were fed a HFD for 4 months to induce hyperlipidemia. Total cholesterol, cholesterol oxidase-peroxidase 
aminophenazone (CHOD-PAP), triglyceride-glycerine, and fat serum were analyzed with colorimetric method. The 
measurement of superoxide dismutase was done with the xanthine oxidase method and malondialdehyde measurement was 
done with the thiobarbituric acid method.
Results: Results showed an increase in antihyperlipidemic characteristics as the concentration of E. palmifolia extract 
(p<0.05) increased. Duncan’s multiple range test also showed an increase in anti-stress oxidation as the concentration of 
C. burmannii extract (p<0.05) increased.
Conclusion: The E225 group showed the most potential as a safe, antihyperlipidemic agent characterized by improvement 
in lipid profile and antioxidant balance.
Keywords: antihyperlipidemic, Cinnamomum burmannii, Eleutherine palmifolia, lipid profile, malondialdehyde, 
superoxide dismutase.
Introduction
Hyperlipidemia is a medical condition character-
ized by the elevation of any or all lipid profiles and/or 
lipoproteins in the blood and is also called hypercho-
lesterolemia or hyperlipoproteinemia [1,2]. Although 
elevated low-density lipoprotein cholesterol (LDL-C) 
is thought to be the best indicator of atherosclerosis 
risk, hyperlipidemia can be determined by elevation 
of total cholesterol (TC) or triglyceride (TG) lev-
els, or by low levels of high-density lipoprotein-C 
(HDL-C) [3]. Elevated LDL-C and TGs in hyperlipid-
emia correlate to cardiovascular disease (CVD), dia-
betes [4], and hypertension [5]. Moreover, ischemic 
heart patients have increased oxidative stress levels 
characterized by an elevation in malondialdehyde 
(MDA) levels [6]. Therefore, hyperlipidemic ther-
apy is needed to decrease cases of diabetes mellitus, 
CVD, and hypertension [4]. Statins are currently used 
for treatment of hyperlipidemia, but they cause side 
effects and myopathy. Side effects of statins com-
monly relate to skeletal muscles and include muscle 
cramping, soreness, weakness, and fatigue [7]. Safe 
hyperlipidemic treatment is needed as an alternative 
to long-term and costly statin treatment.
Phenol is an organic compound with antioxi-
dant and lipid reduction potential [8,9]. Cinnamon 
(Cinnamomum burmannii [Nees & T. Nees] Blume) 
is rich in phenols and flavonoids, including cinnamyl 
alcohol, coumarin, acid cinnamic, cinnamaldehyde, 
anthocyanin, and essential oils with a glucose con-
stituent, protein, crude fat, pectin, etc. C. burmannii 
exhibits high biological activity, acting as an analgesic, 
antibacterial, antidiabetic, antifungal, antioxidant, anti-
rheumatic, antithrombotic, and antitumor agent [10]. 
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The addition of 15% cinnamon powder or 20 mg/body 
weight (BW) to the daily diet for 35 days may reduce 
TC, TGs, and LDL significantly, but not as effective 
as a daily dose of atorvastatin 0.2 mg/kg BW [11]. 
Cinnamaldehyde is the main compound in cinnamon 
bark [12-14]. Administration of 20 mg/kg cinnamal-
dehyde for 4 weeks reduced TG levels and increased 
HDL in spontaneous diabetic mice model of type 2 
diabetes (C57blks/j db/db mice) [15]. Bawang dayak 
(Eleutherine palmifolia (L.) Merr) is a plant endemic 
to Borneo, Indonesia. E. palmifolia has been used 
empirically in therapy for several diseases, such as 
breast cancer, hypertension, diabetes, high cholesterol, 
ulcers, colorectal cancer, and strokes. E. palmifolia 
contains a high level of quercetin [14], which reduces 
the expression of the lipid, oleic acid, and sterol regu-
latory element-binding protein-1, and also inhibits the 
transcription of β-hydroxy β-methylglutaryl-coenzyme 
A (HMG-CoA), glycerol-3-phosphate acyltransferase, 
acetyl-CoA carboxylase, and fatty acid synthetase [16]. 
Long-term hyperlipidemia is characterized by oxida-
tive stress imbalance and results in serious health dis-
orders, such as atherosclerosis, stroke, and heart attack. 
The increase in MDA lipid peroxide inhibits the con-
tractile function of the heart muscle which directly acti-
vates p38 mitogen-activated protein kinase and causes 
muscle cell length reduction and peak shortening [17]. 
At present, supporting scientific data are lacking for the 
use of this plant in hyperlipidemia prevention.
C. burmannii and E. palmifolia have different 
dominant active compounds and mechanisms against 
hyperlipidemia. C. burmannii bark is rich in cin-
namaldehyde, whereas E. palmifolia is rich in quer-
cetin. To maximize the antihyperlipidemic activity of 
both plants, we used a combination extract. Therefore, 
this study aimed to investigate the potential effect of 
C. burmannii and E. palmifolia combination extract on 
the regulation of lipid profiles and antioxidant activity 
by measuring MDA levels in the heart muscle tissue 
of high-fat diet (HFD)-induced hyperlipidemic mice.
Materials and Methods
Ethical approval
Animal maintenance and handling were in 
accordance with Principles of Laboratory Animal 
Care (NIH publication no. 85-23, revised 1985) [18]. 
The type of feed was standard chow diet and water 
ad libitum. Mice were obtained from Rattus Breeding 
Centre, Malang, Indonesia. All the protocols for ani-
mal study were approved by Ethics Commission of the 
Faculty of Science and Technology of UIN Maulana 
Malik Ibrahim Malang (no. 015/EC/KEP. FST/2018).
Preparation of plant extract
Bark of C. burmannii and bulbs of E. palmi-
folia were obtained from UPT Materia Medica, 
Lahore street No. 87, Pesanggrahan, Batu, East Java, 
Indonesia. The plants were dried at 60°C, mashed, and 
filtered through an 80-mesh filter. A 500 g of plant 
powder was dissolved in 96% ethanol (1:3, w:v) for 
72 h. The filtrate was then evaporated with a rotary 
evaporator to obtain the concentrated extract.
Study period and location
This study was conducted from April 15, 
2019 until October 31, 2019 in Animal Physiology 
Laboratorium, Plant Physiology Laboratorium and 
Animal Room, Department of Biology, Faculty of 
Science and Technology, State Islamic University 
of Maulana Malik Ibrahim Malang, Indonesia 
and Biomedical Laboratorium, Muhammadiyah 
University of Malang, Indonesia.  
Design of animal experiment
Thirty-two female Balb/c mice of the same age (8 
weeks) and weight (25 g) were selected for this study. 
Mice were acclimated for 7 days at 25-27°C under 12 
h light-dark cycles. Mice were fed a standard chow diet 
and provided ad libitum access to water. Balb/c mice 
were then divided into eight groups (four mice/group): 
Control normal diet mice (normal), HFD-induced 
hyperlipidemic mice without any treatment (CE0), 
HFD-induced hyperlipidemic mice treated with 3.6 mg/
kg BW atorvastatin (atorvastatin), and HFD-induced 
hyperlipidemic mice treated with a C. burmannii and 
E. palmifolia combination extract in the following 
ratios, 300:0 (C300), 225:75 (C225), 150:150 (CE150), 
75:225 (E225), and 0:300 (E300). Hyperlipidemia was 
induced by a HFD, cholesterol, and propylthiouracil 
(PTU) administration. For 120 days, mice of all HFD 
treatment groups had ad libitum access to HFD pellets 
containing quail egg yolk (10%) and bovine fat (10%). 
Seventeen and one-half mg of cholesterol in 0.3 ml of 
oil was administered through oral gavage. Mice had ad 
libitum access to water containing 0.01% PTU [19].
Serum and heart tissue isolation
After 120 days of treatment with the experimen-
tal diet, animals were sacrificed. Blood and heart tis-
sue were isolated immediately. Blood was collected 
from the ventricles of all mice after fasting for 8 h. 
The blood samples were centrifuged at 1500 rpm for 
15 min. Serum was collected and stored in −20°C for 
further analysis. Heart tissue was isolated and washed 
with phosphate-buffered saline (PBS). A 0.1 g of heart 
organ was homogenized by adding 1 ml PBS, pH 7.0-
7.4. Then, the homogenate was centrifuged at 3000 
rpm, 4°C for 15 min. Lysate heart tissue was isolated 
and stored at −20°C for further superoxide dismutase 
(SOD) and MDA measurement (manual procedure of 
catalog No. E-BC-K020-M, E-BC-K025-S).
Lipid, SOD, and MDA measurement
Levels of TC, TGs, and LDL in serum were mea-
sured using an enzymatic colorimetric method [20] 
with a reagent of TC assay kit (CHOD-phosphate 
oxidase peroxidase [PAP] method) and TG assay kit 
(single reagent, glycerine PAP method; Elabscience®, 
China). Sample absorbance was measured with an EZ 
Read 400 Microplate Reader. SOD level was mea-
sured with the xanthine oxidase method [21] using 
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an SOD activity assay kit (hydroxylamine method; 
Elabscience®). MDA was measured with the thiobar-
bituric acid method (Elabscience®).
Statistical analysis
All of the experimental data were represented 
as mean±standard deviation. Analysis of variance 
and Duncan’s multiple range test were performed 
using SPSS version 16.0 for Windows (SPSS, Inc., 
Chicago, IL, USA). p<0.05 was considered statisti-
cally significant.
Results
Lipid profile of mouse blood serum
To evaluate the antihyperlipidemic effects of 
C. burmannii and E. palmifolia, we analyzed the 
changes in serum lipid profiles of HFD-induced 
hyperlipidemic mice. The results showed that all lipid 
profiles (TC, TGs, and LDL-C) were higher in the 
HFD-treated group than in the normal group (Table-1). 
The concentration of TC significantly (p<0.05) 
decreased in hyperlipidemic mice treated with the sin-
gle and a combination extract of C. burmannii and a 
combination of C. burmannii and E. palmifolia. The 
decrease in TC in the C300 and C225 groups was 
close to the atorvastatin group. The levels of TC in the 
CE150, E225, and E300 groups were not significantly 
different than the normal and atorvastatin groups 
(p>0.05). Furthermore, the single extract of C. bur-
mannii and in combination with E. palmifolia reduced 
TG and LDL-C significantly (p<0.05) compared to 
the hyperlipidemic group. The TGs of the C300 and 
C225 groups were close to the TGs of the atorvastatin 
group, while the levels of TGs and LDL-C in the E225 
and E300 groups were not significantly different from 
normal (p>0.05).
Oxidative stress in heart muscle of mice
The level of oxidative stress was significantly 
increased in the HFD-treated group, which was 
characterized by an elevation in MDA levels and 
reduction in SOD activity. Interestingly, the single 
extract of C. burmannii and in combination with E. 
palmifolia significantly (p<0.05) reduced MDA lev-
els compared to the hyperlipidemic group (CE0; 
Figure-1). All groups of combination extract (exclud-
ing E300) had significantly reduced MDA levels close 
to those of the atorvastatin group. Furthermore, the 
single and/or a combination extract of C. burmannii 
and E. palmifolia increased the activity of SOD sig-
nificantly (excluding E300) compared to the hyper-
lipidemic group to normal level (p<0.05). The E300 
group had a reduced MDA and increased SOD level 
close to that of the atorvastatin group (p>0.05).
Discussion
The present study revealed that the combination 
of 150 mg/kg C. burmannii and 150 mg/kg E. palmi-
folia extract (CE150 group) and the combination of 
75 mg/kg E. palmifolia and 225 mg/kg C. burman-
nii extract (E225 group) exhibited high reduction in 
lipid profile levels compared to the other treatment 
groups. This was supported by the antihyperlip-
idemic activity of each plant. Ethanolic extract of 
C. burmannii reduced lipid and lipoprotein profiles. 
Cinnamon consumption of 120 mg/day to 6 g/day 
for 4-18 weeks reduced TC, TGs, and LDL [22,23]. 
Patients with metabolic syndrome that consumes cin-
namon (six capsules or three g) daily or wheat flour 
showed better results than Febrinda et al. [24] who 
reported ethanolic and water extract of C. burmannii 
in 100 mg/kg BW dose reduced TC and LDL in allox-
an-induced diabetic mice (110 mg/kg BW) for 4 days 
before treatment. However, there was no significant 
effect on HDL and TG levels. The administration of 
cinnamon water extraction at a dose of 100 mg/kg 
BW for 6 weeks significantly reduced cholesterol and 
TGs in HFD- and alloxan-induced rat serum which 
Table-1: Serum lipid profile, MDA, and SOD activity of heart muscle of HFD-induced mice.
Treatment Variable
TC (mg/dl) TG (mg/dl) LDL (mg/dl) SOD (U/ml) MDA (nmol/ml)
Normal 153.32±15.80a 48.48±7.70a 138.80±13.28a 10.04±0.47bc 2.40±0.26b
Atorvastatin 177.93±60.75ab 90.08±4.71b 139.59±8.32a 17.3 ±2.32f 2.40±0.29b
CE0 326.95±61.83c 181.93±36.47e 227.08±35.19c 7.43±0.73a 3.17±0.25c
C300 243.75±28.46b 95.42±4.49b 255.21±43.57c 13.5±1.40e 1.77±0.56ab
C225 210.35±52.41b 83.21±5.54b 219.53±47.85bc 12.76±0.80de 2.03±0.24 ab
CE150 190.04±48.05ab 132.83±18.82c 239.06±8.93c 10.56±1.16bc 1.80±0.48 ab
E225 193.36±31.42ab 53.95±6.31a 170.31±20.85a 11.16±1.01cd 1.96±0.70ab
E300 219.34±55.99ab 45.29±4.84a 173.96±43.63ab 8.71±1.50ab 1.54±0.69a










Normal (healthy mice), atorvastatin (3.6 mg/kg BW of atorvastatin), CE0 (HFD-induced hyperlipidemia mice without 
treatment), C300 (HFD-induced hyperlipidemia mice treated with 300 mg/kg C. burmannii), C225 (HFD-induced 
hyperlipidemia mice treated with 225 mg/kg C. burmannii + 75 mg/kg E. palmifolia), CE150 (HFD-induced hyperlipidemia 
mice treated with 150 mg/kg C. burmannii + 150 mg/kg E. palmifolia), E225 (HFD-induced hyperlipidemia mice 
treated with 75 mg/kg C. burmannii + 225 mg/kg E. palmifolia), and E300 (HFD-induced hyperlipidemia mice treated 
with 300 mg/kg E. palmifolia). TC=Total cholesterol, TG=Triglyceride, LDL=Low-density lipoprotein, SOD=Superoxide 
dismutase, MDA=Malondialdehyde. HFD=High-fat diet, BW=Body weight, E. palmifolia=Eleutherine palmifolia, 
C. burmannii=Cinnamomum burmannii
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previously increased HDL-C and reduced LDL-C 
serum [25]. Water-alcoholic extract of cinnamon at a 
dose of 100 mg/kg BW for 12 weeks reduced TC and 
TG blood serum levels, but they did not reach a nor-
mal level and lowered HDL to the same level as in a 
normal diet [26].
C. burmannii extract can act as an antihyperlipid-
emic agent due to the high amount of cinnamaldehyde 
in the bark. The level of cinnamaldehyde in  cinnamon 
bark is about 65-80%, while in leaves is only 1-5%. 
In addition, cinnamon also contains eugenol, which 
is about 5-10% in the bark and about 70-95% in the 
leaves [27]. This hypothesis is supported by pre-
vious research which found that the addition of 2% 
cinnamaldehyde to the diet for 5 weeks significantly 
reduced the BW of obesity-induced mice. This finding 
also showed a reduction of TC and TGs resulting from 
cinnamaldehyde compound [28].
The antihyperlipidemic effects of combina-
tion extract are supported by the role of single plant 
extract of E. palmifolia, which has several active com-
pounds in the bulb. The main bioactive compounds of 
the ethanolic extract of E. palmifolia are gallic acid 
(97.37 mg), epicatechin gallate (80.17 mg), quer-
cetin (64.8 mg), Eleutherine (33.42 mg), and rutin 
(29.94 mg) [29]. This study showed better results than 
the previous one, which reported that 2% methanolic 
extraction of E. palmifolia for 1 week did not reduce 
TC and TGs in blood serum [30]. Daily administra-
tion of gallic acid protected against hepatic steatosis, 
obesity, hypercholesterolemia, and insulin resistance 
among HFD-induced nonalcoholic fatty liver disease 
mice [31]. Ethanol extract of E. palmifolia at a dose 
of 100-400 mg/kg BW for 14 days did not reduce the 
MDA level in an alloxan-induced diabetic rat [32]. This 
study demonstrated that combination extract could 
significantly increase SOD activity in heart muscle 
of hyperlipidemic mice. This finding was in line with 
other research which proved that ethanolic extract of 
Cinnamomum zeylanicum and Cinnamomum cassia 
at a dose of 600 mg/kg BW significantly increased 
the levels of SOD, glutathione peroxidase (GPx), and 
GSH in the liver of streptozotocin-induced rat [33]. 
The result is also supported by Yuanita et al. [30], who 
found that methanol extract of E. palmifolia signifi-
cantly increased SOD and reduced MDA in chicken 
blood. The highest antioxidant activity of E. palmifo-
lia was found through a DPPH test of extract obtained 
by 50% methanol [34], and a dose of 100-200 mg/kg 
BW increased the activity of SOD, GPx, and catalase 
but not to normal levels [25].
This study showed that the E225 group exhibited 
the best results for improving all parameters. This is 
in accordance with Prakash et al. [35], who proved 
that the four extracts together were more effective 
than a single extract or combination of two extracts 
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against free radicals. Even though the components of 
the extract are the same, different amounts of each 
extract produce different results in reducing the levels 
of lipids, lipoproteins, and oxidative stress [36]. This 
might be caused by several different pathways for 
each parameter and different active compounds in the 
extract, resulting in different synergistic mechanisms.
Several studies have supported the antihyperlip-
idemic mechanisms of combination extract. Quercetin 
from C. burmannii can inhibit cholesterol synthe-
sis by inhibiting the activity of HMG-CoA reduc-
tase [37]. Moreover, tannic acid and gallic acid have 
a high affinity for cholesterol [38]. In addition, the 
inhibitory effects on digestion and absorption of cho-
lesterol in the gastrointestinal tract were induced by 
catechin, epicatechin, and epicatechin gallate from E. 
palmifolia [39]. The inhibition of lipids and choles-
terol absorption during food digestion is very effective 
in ameliorating the increase of lipids and cholesterol 
through external channels, thereby reducing its accu-
mulation in the body. Thus, E. palmifolia has more 
potential as an antihyperlipidemic than C. burmannii. 
Aside from being involved in HMG-CoA reductase 
inhibition, quercetin and kaempferol from C. bur-
mannii also act as powerful natural antioxidants [40]. 
Hydrogen donation is the main mechanism of pheno-
lics as antioxidants. The lower strength of the O–H 
bond present in phenolics corresponds to a higher 
scavenging activity. Quercetin and kaempferol iden-
tified in Cinnamomum species have a C2-C3 double 
bond and a C-3 hydroxyl group, while the most active 
hydroxyl groups are those attached to the C4 and C3 
positions [41]. This research found that a daily dose 
composed of 225 mg/kg E. palmifolia and 75 mg/kg 
C. burmannii showed the most potential effect as an 
antihyperlipidemic agent.
Conclusion
The combination of C. burmannii and E. palmi-
folia extract has more potential effect as a safe antihy-
perlipidemic agent, compared to single plant extracts, 
in improving blood lipid, and lipoprotein profiles 
and also preventing oxidative stress in the hearts of 
hyperlipidemic mice. The combination E225 extract 
(225 mg/kg E. palmifolia and 75 mg/kg C. burmannii) 
is a safe antihyperlipidemic agent due to its neutraliza-
tion of oxidative stress, and normalization of lipid and 
lipoprotein levels, in hyperlipidemic mice.
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